Aa
Arrowhead to accounce 1Q14 financial result on Feb 4
Guys,
Arrowhead, Arc 520's researcher, is due to publish its 1Q14 (first quarter 2014) financial result on Feb 4th. Below are phone numbers to listen in. I have read through its 4Q13 result, which took place on Dec 18 2013. The management did not talk about anything we did not know back then, of course, but offered a lot of details that weren't available in previous conference publications.
As a stocks analyst, I know that listed companies tend to report good things only during such earnings conference, but at least they are not allowed to lie. Q&A sessions usually offers good value too, because the fellow analysts are usually very professional and they ask good questions.
Hope they offer some useful update this time.
Here is the link to its 4Q13 conference transcript, is an interesting read for those have time.
http://seekingalpha.com/article/1968321-arrowhead-research-ground-floor-opportunity-or-biotech-bubble-baby
===== dial-in numbers =====
http://www.businesswire.com/news/home/20140128006438/en/Arrowhead-Report-Fiscal-2014-Quarter-Financial-Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will report its financial results for the fiscal 2014 first quarter ended December 31, 2013, on Tuesday, February 4, 2014, at 4:30 p.m. Eastern time. To participate in the conference call, please dial 877-300-8521 (toll free from the US), 855-669-9657 (toll free from Canada), or 412-317-6026 (for international callers). Investors may also access a live audio webcast of this conference call on the Company's website at http://www.arrowheadresearch.com/presentations.
A replay of the webcast will be available approximately one hour after the conclusion of the call and will remain available for 90 days. An audio replay will also be available approximately two hours after the conclusion of the call and will be available for 30 days. The audio replay can be accessed by dialing 877-870-5176 (toll free from the US and Canada), or 858-384-5517 (for international callers) and entering Event ID 10040388.
Arrowhead, Arc 520's researcher, is due to publish its 1Q14 (first quarter 2014) financial result on Feb 4th. Below are phone numbers to listen in. I have read through its 4Q13 result, which took place on Dec 18 2013. The management did not talk about anything we did not know back then, of course, but offered a lot of details that weren't available in previous conference publications.
As a stocks analyst, I know that listed companies tend to report good things only during such earnings conference, but at least they are not allowed to lie. Q&A sessions usually offers good value too, because the fellow analysts are usually very professional and they ask good questions.
Hope they offer some useful update this time.
Here is the link to its 4Q13 conference transcript, is an interesting read for those have time.
http://seekingalpha.com/article/1968321-arrowhead-research-ground-floor-opportunity-or-biotech-bubble-baby
===== dial-in numbers =====
http://www.businesswire.com/news/home/20140128006438/en/Arrowhead-Report-Fiscal-2014-Quarter-Financial-Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will report its financial results for the fiscal 2014 first quarter ended December 31, 2013, on Tuesday, February 4, 2014, at 4:30 p.m. Eastern time. To participate in the conference call, please dial 877-300-8521 (toll free from the US), 855-669-9657 (toll free from Canada), or 412-317-6026 (for international callers). Investors may also access a live audio webcast of this conference call on the Company's website at http://www.arrowheadresearch.com/presentations.
A replay of the webcast will be available approximately one hour after the conclusion of the call and will remain available for 90 days. An audio replay will also be available approximately two hours after the conclusion of the call and will be available for 30 days. The audio replay can be accessed by dialing 877-870-5176 (toll free from the US and Canada), or 858-384-5517 (for international callers) and entering Event ID 10040388.
they must be doing well...i've been watching this stock since it was $1.90...yesterday closed over $17
I can't recall any concerns regarding ARC520 as I am not an expert. Studyforhope did raise many concerns, one was silencing of antigens production will lead to "lights turning off the Xmas tree". I am always hopeful until clinical trials prove otherwise.
I know at one time you were concerned that ARC520 may not reduce Cccdna quickly enough. Do you still share that concern?
That will be wonderful. You can just ask whether any clinical trial coming up as friends of yours are interested.
I am in Hong Kong. We are seeing a doctor hopefully soon in the hospital that we know should be the place where the ARC-520 trials are taking place. We will try to ask the doctor about any update, should he be willing to talk.
The hospital is a public hospital, so it's extremely slow. Hope we got a slot soon.
The hospital is a public hospital, so it's extremely slow. Hope we got a slot soon.
Hope they will announce the approval and a start date for their phase 2 in HK.
Have an Answer?
You are reading content posted in the Hepatitis B Community
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
